- €941.84m
- €853.31m
- €74.00m
- 58
- 18
- 73
- 45
Annual income statement for Philogen SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.78 | 2.5 | 23.7 | 23.1 | 74 |
| Cost of Revenue | |||||
| Gross Profit | -1.85 | -4.34 | 14 | 9.26 | 58.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16.9 | 19.3 | 23.5 | 32 | 36.3 |
| Operating Profit | -12.1 | -16.8 | 0.24 | -8.84 | 37.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.4 | -15.2 | -4.36 | -6.18 | 40.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.3 | -15.7 | -5.38 | -6.16 | 45.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.3 | -15.7 | -5.38 | -6.16 | 45.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.3 | -15.7 | -5.38 | -6.16 | 45.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.327 | -0.377 | -0.132 | -0.153 | 1.12 |
| Dividends per Share |